医学
肺癌
靶向治疗
疾病
肿瘤科
癌症
重症监护医学
内科学
作者
Valentina Favorito,Ilaria Ricciotti,Andrea De Giglio,Laura Fabbri,Renata Seminerio,Alessandro Di Federico,Eleonora Gariazzo,Silvia Costabile,Giulio Metro
标识
DOI:10.1080/14728214.2024.2331139
摘要
Current research in EGFR-mutated NSCLC focuses on the management of drug resistance and uncommon mutations, as well as on the opportunity to extend targeted therapies' field of action to earlier stages of disease.
科研通智能强力驱动
Strongly Powered by AbleSci AI